NURIX THERAPEUTICS INC shareholders Q2 2023

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 126 filers reported holding NURIX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

NURIX THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Jasper Ridge Partners, L.P. 95,711$956,1530.05%
CORNERCAP INVESTMENT COUNSEL INC 18,756$187,3720.03%
ClariVest Asset Management LLC 59,817$5970.03%
GSA CAPITAL PARTNERS LLP 17,568$1760.02%
ALGERT GLOBAL LLC 42,371$4230.02%
Trexquant Investment LP 55,854$557,9810.02%
KENNEDY CAPITAL MANAGEMENT LLC 55,904$558,4810.01%
PICTET ASSET MANAGEMENT SA 930,914$9,299,8310.01%
PROFUND ADVISORS LLC 21,249$212,2780.01%
BESSEMER GROUP INC 357,287$3,5690.01%
B. Metzler seel. Sohn & Co. AG 54,076$540,2190.01%
Connor, Clark & Lunn Investment Management Ltd. 130,494$1,303,6350.01%
Rafferty Asset Management, LLC 114,488$1,143,7350.01%
Leucadia National 62,000$619,3800.01%
Avalon Trust Co 7,056$70,4900.01%
PANAGORA ASSET MANAGEMENT INC 89,082$889,9290.01%
LOS ANGELES CAPITAL MANAGEMENT LLC 108,850$1,087,4120.00%
NOMURA HOLDINGS INC 130,040$1,299,1000.00%
EXCHANGE TRADED CONCEPTS, LLC 12,339$123,2670.00%
Graham Capital Management, L.P. 10,783$107,7220.00%
External links

This page lists NURIX THERAPEUTICS INC's shareholders in Q2 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.